9,369
Views
13
CrossRef citations to date
0
Altmetric
Research Paper

Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response

, , , , , , , , , , ORCID Icon & ORCID Icon show all
Article: 2155018 | Received 06 May 2022, Accepted 30 Nov 2022, Published online: 15 Dec 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xuran Cui, Xiaolong Xu, Yahui Hu, Rui Li & Qingquan Liu. (2024) Mechanism of Qiguiyin Decoction Treats Pulmonary Infection Caused by Pseudomonas aeruginosa Based on Gut Microbiota and Metabolomics. Infection and Drug Resistance 16, pages 3073-3084.
Read now

Articles from other publishers (12)

Thananya Jinato, Songtham Anuntakarun, Nantawat Satthawiwat, Natthaya Chuaypen & Pisit Tangkijvanich. (2024) Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma. Applied Microbiology and Biotechnology 108:1.
Crossref
Zuoquan Xie, Jingjing Huang, Guangqiang Sun, Shen He, Zhiyu Luo, Linna Zhang, Liang Li, Min Yao, Chen Du, Wenjuan Yu, Yuan Feng, Dabing Yang, Jing Zhang, Changrong Ge, Huafang Li & Meiyu Geng. (2024) Integrated multi-omics analysis reveals gut microbiota dysbiosis and systemic disturbance in major depressive disorder. Psychiatry Research 334, pages 115804.
Crossref
Elias Kouroumalis, Ioannis Tsomidis & Argyro Voumvouraki. (2024) Viral Liver Disease and Intestinal Gut–Liver Axis. Gastrointestinal Disorders 6:1, pages 64-93.
Crossref
Patricia P. BloomJasmohan S. Bajaj. (2024) The Current and Future State of Microbiome Therapeutics in Liver Disease. American Journal of Gastroenterology 119:1S, pages S36-S41.
Crossref
Mei-zhu Gao, Lin-lin Xu, Yang Li, Xin Wang, Pei Chen, Su-fang Shi, Li-jun Liu, Ji-cheng Lv, Fu-Yuan Hong, Hong Zhang & Xu-jie Zhou. (2024) Hepatitis B Virus Status and Clinical Outcomes in IgA Nephropathy. Kidney International Reports.
Crossref
Shi-Qin Li, Yue Shen, Jun Zhang, Cheng-Zhao Weng, Sheng-Di Wu & Wei Jiang. (2023) Immune modulation of gut microbiota and its metabolites in chronic hepatitis B. Frontiers in Microbiology 14.
Crossref
Reham Magdy Wasfy, Babacar Mbaye, Patrick Borentain, Maryam Tidjani Alou, Maria Leticia Murillo Ruiz, Aurelia Caputo, Claudia Andrieu, Nicholas Armstrong, Matthieu Million & Rene Gerolami. (2023) Ethanol-Producing Enterocloster bolteae Is Enriched in Chronic Hepatitis B-Associated Gut Dysbiosis: A Case–Control Culturomics Study. Microorganisms 11:10, pages 2437.
Crossref
Quanzheng Zhang, Jinhua Zhou, Xiaoxiao Zhang, Rui Mao & Chuan Zhang. (2023) Mendelian randomization supports causality between gut microbiota and chronic hepatitis B. Frontiers in Microbiology 14.
Crossref
Ning Xie, Ziwei Wang, Qiuai Shu, Xiru Liang, Jinhai Wang, Kaichun Wu, Yongzhan Nie, Yongquan Shi, Daiming Fan & Jian Wu. (2023) Association between Gut Microbiota and Digestive System Cancers: A Bidirectional Two-Sample Mendelian Randomization Study. Nutrients 15:13, pages 2937.
Crossref
Jiajia Yang, Dawei Wang, Yuancheng Li, Hongmei Wang, Qiang Hu & Ying Wang. (2023) Metabolomics in viral hepatitis: advances and review. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Shuyu Liu & Xilan Yang. (2023) Intestinal flora plays a role in the progression of hepatitis-cirrhosis-liver cancer. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Luan Luong Chu, Nguyen Quang Huy & Nguyen Huu Tung. (2023) Microorganisms for Ginsenosides Biosynthesis: Recent Progress, Challenges, and Perspectives. Molecules 28:3, pages 1437.
Crossref